Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0120
0.00 (0.00%)
Aug 5, 2026, 3:24 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 24.31 million as of August 5, 2026. Its market cap has increased by 161.91% in one year.
Market Cap
24.31M
Enterprise Value
22.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 24.31M, an increase of 99.76%. That is a compound annual growth rate of 3.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 24.31M | 2.81% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 47.76M |
| Imugene | 34.93M |
| Noxopharm | 24.27M |
| NeuroScientific Biopharmaceuticals | 24.16M |
| Neurotech International | 22.40M |
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| EZZ Life Science Holdings | 21.89M |